创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

胡建星, 徐旻, 陈红明, 张佩宇, 马健. 人工智能算法在全新药物结构设计中的应用进展[J]. 药学进展, 2021, 45(7): 484-493.
引用本文: 胡建星, 徐旻, 陈红明, 张佩宇, 马健. 人工智能算法在全新药物结构设计中的应用进展[J]. 药学进展, 2021, 45(7): 484-493.
HU Jianxing, XU Min, CHEN Hongming, ZHANG Peiyu, MA Jian. Advances in the Application of Artificial Intelligence Algorithms in the Design of Novel Drug Structures[J]. Progress in Pharmaceutical Sciences, 2021, 45(7): 484-493.
Citation: HU Jianxing, XU Min, CHEN Hongming, ZHANG Peiyu, MA Jian. Advances in the Application of Artificial Intelligence Algorithms in the Design of Novel Drug Structures[J]. Progress in Pharmaceutical Sciences, 2021, 45(7): 484-493.

人工智能算法在全新药物结构设计中的应用进展

Advances in the Application of Artificial Intelligence Algorithms in the Design of Novel Drug Structures

  • 摘要: 人工智能算法在药物设计中得到了越来越广泛的重视,并取得了卓著的研究成果。分子生成算法作为其中一类独特的应用技术,已开始显现出能够取代传统药化专家设计的潜力。为了更好地解决药物发现中的实际问题,精确的分子性质预测模型、三维结构生成和统一的测试数据集都是非常必要的。总结了人工智能算法在全新药物结构设计中的应用进展,重点介绍了不同的分子表征形式、神经网络架构的技术细节及优缺点等。

     

    Abstract: Artificial intelligence (AI) algorithm has attracted an increasing amount of attention and achieved some amazing progress in drug design. Molecular generation as a unique applied technique demonstrates the potential to replace traditional drug design by medicinal chemists. To better utilize it in solving real problems, it is essential to have an accurate molecular property prediction model, a 3D structure generation technique and a unified benchmark. This review summarizes recent advances in the application of AI algorithms in the design of novel drug structures, with particular focus on the technical details as well as the advantages and disadvantages of different molecular representation forms and neural network architectures.

     

/

返回文章
返回